Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering

2 years ago

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company…

Clade Therapeutics Announces the Acquisition of Gadeta B.V.

2 years ago

Expands Clade’s pipeline and broadens its platform with:- proprietary gamma/delta (g/d) TCR universal targeting platform technology,- g/d TCR candidate integrated…

Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration

2 years ago

Refinancing of Current $400M Debt at Lower Cost and Improved Amortization Schedule Blackstone to also Purchase $30M of Amicus Common…

Axonics to Report Third Quarter 2023 Financial Results on October 30

2 years ago

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the…

Mark Cuban Cost Plus Drug Company, PBC Joins Forces with Famlee to Revolutionize Access to Home-Based Step-Therapy Fertility Treatment, Providing an Affordable Path to Parenthood

2 years ago

PORTLAND, OR / ACCESSWIRE / October 2, 2023 / Famlee is revolutionizing the landscape of affordable and accessible women's fertility…

Supporting Indigenous Communities: LifeLabs’ Efforts to Provide Health Equity on National Day of Truth and Reconciliation

2 years ago

Marianne McRae, LifeLabs Mobile Laboratory Assistant Marianne McRae, Mobile Laboratory Assistant visiting Qualicum First Nations clinicToronto, Ontario, Sept. 30, 2023…

SmileDirectClub Seeks to Execute Comprehensive Recapitalization to Strengthen the Business for Sustainable Growth

2 years ago

Company Intends to Maintain Normal Operations, Transforming Smiles Without DisruptionNASHVILLE, Tenn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq:…

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2 years ago

SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) --  Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform…

GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression

2 years ago

DUBLIN, Ireland, Sept. 29, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming…

Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to November 3, 2023

2 years ago

MIAMI, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”), a special purpose…